Biogen on Thursday reported Second-quarter earnings and revenue beat estimates and raised full-year guidance as ...
The breakthrough Alzheimer's drug Leqembi slowed the progression of the disease in patients over three ...
European Medicines Agency on Friday rejected the Alzheimer treatment Leqembi from Biogen And Eisaiwhich represents ...